BioLineRx Ltd.
2 HaMa’ayan Street
Modi’in 7177871, Israel
February 11, 2019
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Todd Schiffman
| Re: |
BioLineRx Ltd.’s Registration Statement on Form F-3 (File No. 333-229021) (the “Registration Statement”)
|
Ladies and Gentlemen:
BioLineRx Ltd. (the “Company”), pursuant to Rule 461 under the Securities Act of 1933, as amended, hereby
requests the Securities and Exchange Commission (the “Commission”) to accelerate the effective date of the above-referenced Registration Statement and declare the Registration Statement effective as of 4:30 p.m., eastern time, on February 13, 2019,
or as soon thereafter as practicable. The Company also requests the Commission to specifically confirm such effective date and time to the Company in writing.
Please contact Anna T. Pinedo of Mayer Brown LLP with any questions at (212) 506-2275. Thank you for your
assistance with this filing.
|
Sincerely yours,
|
|||
|
BIOLINERX LTD.
|
|||
|
By:
|
/s/ Philip Serlin
|
||
|
Philip Serlin
|
|||
|
Chief Executive Officer
|
|||
cc: Mayer Brown LLP